Q2 2026 SINTX Technologies Inc Earnings Call Transcript
Key Points
- Second-quarter revenue increased 199% year-over-year to $452,000, with product revenue up 347% to $447,000.
- Gross profit surged 388% to $278,000, and gross margin improved to approximately 62% from 38% a year ago.
- Received purchase orders from multiple contract manufacturing customers exceeding $3.2 million, providing commercial visibility into 2027.
- SINAPTIC Foot and Ankle Osteotomy Wedge System achieved FDA 510(k) clearance and first clinical use, with initial commercial revenue recognized.
- Completed financing transactions generating approximately $5 million in gross proceeds, including a private placement and ATM sales, with $5.1 million remaining ATM capacity.
- Substantial doubt remains regarding the company's ability to continue as a going concern, with only $3.6 million in cash at quarter end.
- Net loss widened to $2.7 million in Q2 2026, up from $2.3 million in the prior-year quarter.
- Operating expenses increased 16% to $3.2 million, driven by higher G&A and sales and marketing costs.
- Cash used in operating activities rose to $5.3 million in the first half of 2026, up from $3.7 million a year ago.
- Revenue guidance for Q3 and Q4 2026 is modest ($900K-$1.1M and $1M-$1.3M, respectively) and subject to significant uncertainty.
Good day, and welcome to the SINTX Technologies second-quarter 2026 earnings call. All participants are currently in listen-only mode. As a reminder, today's call is being recorded.
I would like to turn the call over to SINTX Technologies Chief Legal Officer, Kevin Ontiveros.
Thank you, operator, and good afternoon, everyone. Earlier today, SINTX Technologies issued its financial results for the quarter ended June 30, 2026 and filed its quarterly report on Form 10-Q with the Securities and Exchange Commission. The earnings release and Form 10-Q are available in the investor relations section of the company's website, and a replay of this call will be available following the conclusion of today's event.
Before we begin, I would like to remind everyone that statements made during this call that are not statements of historical fact are forward-looking statements. These statements include, among other things, expectations regarding revenue growth, customer orders, production and shipping
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
